These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 15749894

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner.
    Chatterjee S, Dwivedi VP, Singh Y, Siddiqui I, Sharma P, Van Kaer L, Chattopadhyay D, Das G.
    PLoS Pathog; 2011 Nov; 7(11):e1002378. PubMed ID: 22102818
    [Abstract] [Full Text] [Related]

  • 3. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.
    Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, Morin PM, Marks CB, Padiyar J, Goulding C, Gingery M, Eisenberg D, Russell RG, Derrick SC, Collins FM, Morris SL, King CH, Jacobs WR.
    Proc Natl Acad Sci U S A; 2003 Oct 14; 100(21):12420-5. PubMed ID: 14557547
    [Abstract] [Full Text] [Related]

  • 4. ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.
    Kupz A, Zedler U, Stäber M, Perdomo C, Dorhoi A, Brosch R, Kaufmann SH.
    J Clin Invest; 2016 Jun 01; 126(6):2109-22. PubMed ID: 27111234
    [Abstract] [Full Text] [Related]

  • 5. Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gamma.
    Junqueira-Kipnis AP, Basaraba RJ, Gruppo V, Palanisamy G, Turner OC, Hsu T, Jacobs WR, Fulton SA, Reba SM, Boom WH, Orme IM.
    Immunology; 2006 Oct 01; 119(2):224-31. PubMed ID: 17005003
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P, Majlessi L, Brosch R, Smith D, Bancroft G, Clark S, Williams A, Leclerc C, Cole ST.
    J Infect Dis; 2004 Jul 01; 190(1):115-22. PubMed ID: 15195250
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X, Teng X, Jing Y, Ma J, Tian M, Yu Q, Zhou L, Wang R, Wang W, Li L, Fan X.
    Appl Microbiol Biotechnol; 2015 Dec 01; 99(24):10587-95. PubMed ID: 26363555
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.
    Pym AS, Brodin P, Brosch R, Huerre M, Cole ST.
    Mol Microbiol; 2002 Nov 01; 46(3):709-17. PubMed ID: 12410828
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo.
    Grace PS, Ernst JD.
    J Immunol; 2016 Jan 01; 196(1):357-64. PubMed ID: 26573837
    [Abstract] [Full Text] [Related]

  • 14. The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice.
    Roche CM, Smith A, Lindsey DR, Meher A, Schluns K, Arora A, Armitige LY, Jagannath C.
    Tuberculosis (Edinb); 2011 Dec 01; 91 Suppl 1():S96-104. PubMed ID: 22082615
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.
    Dai FY, Wang JF, Gong XL, Bao L.
    Hum Vaccin Immunother; 2017 Jun 03; 13(6):1-8. PubMed ID: 28301284
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ, Chen X, Hu T, Meng C, Wang XB, Rao Y, Zhang XM, Yin YL, Pan ZM, Jiao XA.
    Front Cell Infect Microbiol; 2016 Jun 03; 6():3. PubMed ID: 26858942
    [Abstract] [Full Text] [Related]

  • 20. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y, Hirayama Y, Takii T, Yamamoto S, Kobayashi K, Matsumoto S.
    Vaccine; 2011 Sep 16; 29(40):6881-7. PubMed ID: 21803102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.